Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
601 to 620 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA226864 | Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition | 1 | 2021 |
| R01DK095835 | Cellular and Molecular Mechanisms of Renal Fibrosis | 1 | 2021 |
| R01DK115454 | Transcript decay regulates hematopoietic aging | 1 | 2021 |
| R01EB025209 | High throughput optical coherence tomography (OCT)-based imaging platform for label-free, non-invasive characterization of 3D tumor spheroids. | 1 | 2021 |
| R01ES014811 | A Systems Approach to Mapping the DNA Damage Response | 1 | 2021 |
| R01EY015473 | Gene-Environment Interactions in Glaucoma | 1 | 2021 |
| R01EY027924 | Optic Nerve Head Mechanobiology in Glaucoma | 1 | 2021 |
| R01GM121505 | The role of reorganization energy in achieving selective kinase inhibition | 1 | 2021 |
| R01GM121920 | Microfluidic Chip for the Analysis of Cell-Surface Proteins | 1 | 2021 |
| R01GM122855 | Mechanochemical Signaling Dynamics in Epithelial-Mesenchymal Transition | 1 | 2021 |
| R01GM130147 | Insight into the RNA processing and decay pathways critical for proper neuronal development and function through focus on mutations that cause Pontocerebellar Hypoplasia | 1 | 2021 |
| R01HL061483 | Axes of Oncometabolism in the Heart | 1 | 2021 |
| R01HL114120 | Endogenous and exogenous mechanisms that promote myocardial remuscularization in post infarction LV remodeling | 1 | 2021 |
| R01HL136586 | Role of Sca-1+Cardiac Fibroblasts in Inflammatory Heart Disease` | 1 | 2021 |
| R01HL137995 | Biomarker of Lung Disease in African Americans | 1 | 2021 |
| R01HL138023 | Mesenchymal Stem Cell Exosome in Efferocytosis of Apoptotic Cardiomyocytes and Repair after Myocardial Ischemia | 1 | 2021 |
| R01HL141195 | X-Linked Inhibitor of Apoptosis in Fibroblast Phenotypes and Lung Fibrosis | 1 | 2021 |
| R01HL141570 | Perfusable 3D human cardiac constructs for heart regeneration | 1 | 2021 |
| R01LM012595 | Reconstruction and Modeling of Dynamical Molecular Networks | 1 | 2021 |
| R01MH113005 | Revealing the transcriptomic basis of neuronal identity through functional meta-analysis | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=31